Daliah Tsoref
Impact in
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
Papers in
-
- Ovarian cancer diagnosis and treatment 6
- Oncology 6
- Cancer Immunotherapy and Biomarkers 2
- PARP inhibition in cancer therapy 2
- Co-authors
- Amit M. Oza (4 shared papers)Susie K. Lau (1 shared paper)Laurie M. Elit (1 shared paper)Suzanne Kamel‐Reid (1 shared paper)Susan L. Ellard (1 shared paper)James Joseph Biagi (1 shared paper)Helen J MacKay (1 shared paper)Ming‐Sound Tsao (1 shared paper)
- Journals
- Breast Cancer Research and Treatment (4 papers)Gynecologic Oncology (2 papers)Current Opinion in Oncology (1 paper)Carcinogenesis (1 paper)Cell (1 paper)
- Partner nations
- IsraelCanadaUnited Kingdom
In The Last Decade
Daliah Tsoref
20 papers receiving 544 citations
Peers
Comparison fields: 5 of 38
- Obstetrics and Gynecology 113
- Oncology 235
- Reproductive Medicine 92
- Immunology 76
- Cancer Research 27
Countries citing papers authored by Daliah Tsoref
This map shows the geographic impact of Daliah Tsoref's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daliah Tsoref with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daliah Tsoref more than expected).
Fields of papers citing papers by Daliah Tsoref
This network shows the impact of papers produced by Daliah Tsoref. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daliah Tsoref. The network helps show where Daliah Tsoref may publish in the future.
Co-authors
The 25 scholars most cited alongside Daliah Tsoref, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 133 | |
| 2 | 2017 | 127 | |
| 3 | 2014 | 77 | |
| 4 | 2023 | 61 | |
| 5 | 2016 | 31 | |
| 6 | 2011 | 30 | |
| 7 | 2023 | 19 | |
| 8 | 2020 | 14 | |
| 9 | 2011 | 13 | |
| 10 | 2020 | 11 | |
| 11 | 2014 | 10 | |
| 12 | 2018 | 5 | |
| 13 | 2020 | 5 | |
| 14 | 2017 | 4 | |
| 15 | 2018 | 3 | |
| 16 | Neoadjuvant Chemotherapy for Elderly Patients with Advanced Stage Ovarian Carcinoma. | 2020 | 2 |
| 17 | 2021 | 2 | |
| 18 | 2022 | 2 | |
| 19 | 2013 | 1 | |
| 20 | 2019 | 1 |
About Daliah Tsoref
Daliah Tsoref is a scholar working on Reproductive Medicine, Oncology, Obstetrics and Gynecology, Genetics and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 551 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (6 papers), Cancer Immunotherapy and Biomarkers (2 papers), Endometrial and Cervical Cancer Treatments (2 papers), BRCA gene mutations in cancer (2 papers), PARP inhibition in cancer therapy (2 papers), Cervical Cancer and HPV Research (1 paper), Inflammatory mediators and NSAID effects (1 paper) and T-cell and B-cell Immunology (1 paper). The work is most often cited by research in Obstetrics and Gynecology (113 citations), Oncology (235 citations), Reproductive Medicine (92 citations), Immunology (76 citations) and Cancer Research (27 citations). Daliah Tsoref has collaborated with scholars based in Israel, Canada and United Kingdom. Frequent co-authors include Amit M. Oza, Susie K. Lau, Laurie M. Elit, Suzanne Kamel‐Reid, Susan L. Ellard, James Joseph Biagi, Helen J MacKay, Ming‐Sound Tsao, Prafull Ghatage and Stephen A. Welch. Their work appears in journals such as Breast Cancer Research and Treatment, Gynecologic Oncology, Current Opinion in Oncology, Carcinogenesis and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.